Man who Picked Bitcoin at $428 Says "Buy Genesis"
He Picked Bitcoin (And Dogecoin) in 2016. What He's Recommending Now Could Turn Heads...
Watch more here!

VACC Insider Trading (Vaccitech)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $12,031,875.00
Insider Selling (Last 12 Months): $0.00

Vaccitech Insider Trading History Chart

This chart shows the insider buying and selling history at Vaccitech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vaccitech Share Price & Price History

Current Price: $15.40
Price Change: Price Decrease of -0.56 (-3.51%)
As of 06/24/2021 05:30 PM ET

This chart shows the closing price history over time for VACC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!

Vaccitech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/4/2021Christopher EllisCOOBuy75$17.00$1,275.0075View SEC Filing Icon  
5/4/2021Graham GriffithsInsiderBuy100$17.00$1,700.00100View SEC Filing Icon  
5/4/2021Karen A DawesDirectorBuy1,700$17.00$28,900.001,700View SEC Filing Icon  
5/4/2021Sciences Innovation Plc OxfordMajor ShareholderBuy600,000$17.00$10,200,000.004,832,142View SEC Filing Icon  
4/30/2021M&G Investment Management LtdMajor ShareholderBuy125,000$14.40$1,800,000.00View SEC Filing Icon  
See Full Table
Insider Trading at Vaccitech?
Sign-up to receive's daily insider buying and selling report for Vaccitech and related companies.

SEC Filings (Institutional Ownership Changes) for Vaccitech (NASDAQ:VACC)

Vaccitech logo
Vaccitech plc is a clinical-stage biopharmaceutical company that engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Its therapeutic programs include VTP-300, indicated for the treatment of chronic hepatitis B infection; VTP-200, indicated for the treatment of human papilloma virus infection; VTP-850, indicated for the treatment of prostate cancer; and VTP-600, indicated for the treatment of non-small cell lung cancer. The company's prophylactic programs include VTP-400 for the prevention of herpes zoster or shingles; and VTP-500 for the prevention of Middle East respiratory syndrome. In addition, it is developing AZD1222, a COVID-19 vaccine. Vaccitech plc was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc on March 31, 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, United Kingdom.
Read More on Vaccitech

Today's Range

Now: $15.40
Low: $15.38
High: $16.10

50 Day Range


52 Week Range

Now: $15.40
Low: $12.25
High: $17.99


18,086 shs

Average Volume

100,350 shs

Market Capitalization

$528.65 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Vaccitech?

Vaccitech's top insider shareholders include:
  1. Sciences Innovation Plc Oxford (Major Shareholder)
  2. Karen A Dawes (Director)
  3. Graham Griffiths (Insider)
  4. Christopher Ellis (COO)
  5. M&G Investment Management Ltd (Major Shareholder)
The 32-Second Options Trading "Training Video"
Watch his 32-second options trading "training video" here.
Continue Reading